Artwork
iconShare
 
Manage episode 483867623 series 1602067
Content provided by Listening In (with Permission...) and Catalyst for Payment Reform. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Listening In (with Permission...) and Catalyst for Payment Reform or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode of Listening In (With Permission), Shawn Gremminger, President and CEO of the National Alliance of Healthcare Purchaser Coalitions, joins Andréa Caballero of Catalyst for Payment Reform to dive into a pressing but often overlooked issue: the impact of the 340B Drug Pricing Program on pharmacy costs for employers and healthcare purchasers. The 340B program, originally intended to support safety-net hospitals and community health centers, has expanded drastically over the years. Today, it's the second-largest drug purchasing program in the U.S., with an explosive $65 billion price tag. But what does this mean for employers and employees in the commercial market?
  continue reading

145 episodes